Why precision medicines for oncology demands precision engagement

MedCity News | May 24, 2019

Life sciences companies overwhelmed with large volumes of information and data available – both in terms of therapies and patient-reported outcomes – must establish a more efficient, bi-directional communication model with care teams to succeed.

Read more ›

Survey: Patient influencers trust social media more than pharma websites

MM&M | April 16, 2019

Patient influencers trust social media groups more than pharma websites for health information, according to a survey from Wego Health.

Read more ›

Walking the walk: How pharma companies can deliver patient-centric experiences

BIOPHARMADIVE | April 16, 2019

What does it mean to walk the walk and, more importantly, how can organizations ensure that a focus on patient centricity not only benefits patients but also drives business success?

Read more ›

In R&D, small biotechs hold their own against big pharma

BIOPHARMADIVE | April 23, 2019

Emerging biopharma companies patented almost two-thirds of new drugs in 2018, while large pharma patented one-quarter

Read more ›

A rough guide to…advisory boards

PMLive | March 23, 2016

Our intrepid writers take us on a journey through advisory boards and show that pre-trip planning is the pathway to perfection

Read more ›

Nine Key Elements to Ensure Advisory Board Success

PM360 | June 17, 2014

The relationship between pharmaceutical companies and medical stakeholders will need to evolve thanks to the greater public scrutiny these relationships will now receive under various regulatory changes including the Sunshine Act.

Read more >

Pharma Medical Affairs: 2020 and Beyond

McKinsey & Company | 2014

Pharma’s Medical Affairs faces growing internal and external challenges as
well as new opportunities

Read more >

Pharmaceutical companies should focus on medication adherence to improve revenue

Healthcare Finance Network | June 14, 2018

A more concerted effort by pharmaceutical companies to drive medication adherence could help them increase their sales growth and margin profile.

Read more >

Doctors and pharmaceutical companies work together to improve patient care-not pad pockets | Opinion

Penn Live | August 22, 2018

In recent years there has been a push towards more transparency regarding the financial relationship between physicians and pharmaceutical companies.

Read more >

An Unwarranted Attack on Rare Disease Research

Forbes | August 28, 2018

Is the FDA really “less fussy about the kind of data that it requires for approval of a new drug for a rare disease“?

Read more >